The Company is in the applied life sciences industry with a focus on proprietary yeast-based technology platforms to develop functional, market-ready microorganisms for the global healthcare, agriculture, food and beverage, and chemicals industries. Current research and new product development: World’s first oral delivery system for RNA RNAi production and delivery for gastrointestinal therapies for animal and human, RNAi production and delivery as a biopesticide for crop protection. Their current products include commercially available yeast strains that prevent the formation of two separate and significant naturally occurring contaminants: acrylamide in carbohydrate-rich foods and coffee, and hydrogen sulfide in wine, beer, and cider. It was founded in 2013 by John Husnick and Maurice Boucher. It is headquartered in Vancouver, British Columbia.Something looks off?